
  
    
      
        Background_NNP
        
        Staphylococcus_NNP aureus_NN is_VBZ the_DT most_RBS
        common_JJ cause_NN of_IN osteomyelitis_NNS ,_, a_DT disease_NN often_RB refractory_JJ
        to_TO treatment_NN and_CC subject_JJ to_TO recurrence_NN ._. Traditional_JJ
        treatment_NN for_IN osteomyelitis_NNS involves_VBZ surgical_JJ debridement_NN
        of_IN infected_JJ tissue_NN ,_, coupled_VBN with_IN systemic_JJ antibiotic_JJ
        therapy_NN ._. Only_RB a_DT few_JJ decades_NNS ago_RB ,_, the_DT majority_NN of_IN 
        S_NNP ._. aureus_NN strains_NNS associated_VBN with_IN
        osteomyelitis_NNS were_VBD susceptible_JJ to_TO antibiotics_NNS including_VBG
        methicillin_NN ._. However_RB ,_, the_DT emergence_NN of_IN antibiotic_JJ
        resistance_NN among_IN strains_NNS of_IN 
        S_NNP ._. aureus_NN has_VBZ rendered_VBN methicillin_NN
        and_CC many_JJ other_JJ antibiotics_NNS less_RBR effective_JJ against_IN this_DT
        organism_NN ._. Consequently_RB ,_, there_EX is_VBZ an_DT urgent_JJ need_NN for_IN the_DT
        development_NN of_IN novel_NN therapies_NNS for_IN the_DT treatment_NN of_IN
        osteomyelitis_NNS ._.
        
        S_NNP ._. aureus_NN is_VBZ a_DT capable_JJ bone_NN pathogen_NN ,_,
        in_IN part_NN ,_, because_IN it_PRP possesses_VBZ several_JJ cell_NN surface_NN adhesion_NN
        molecules_NNS that_WDT facilitate_VBP its_PRP$ binding_JJ to_TO bone_NN matrix_NN ._.
        Binding_NNP involves_VBZ a_DT family_NN of_IN adhesins_NNS that_WDT interact_NN with_IN
        extracellular_NN matrix_NN components_NNS ,_, and_CC these_DT adhesins_NNS have_VBP
        been_VBN termed_VBN microbial_NN surface_NN components_NNS recognizing_VBG
        adhesive_NN matrix_NN molecules_NNS (_( MSCRAMMs_NNP )_) [_NN 1_CD ]_NN ._. Specific_JJ
        MSCRAMMs_NNP are_VBP responsible_JJ for_IN localization_NN of_IN 
        S_NNP ._. aureus_NN to_TO particular_JJ tissues_NNS ,_, and_CC
        include_VBP fibronectin-binding_JJ proteins_NNS (_( FnBPs_NNP )_) [_NN 2_CD 3_CD ]_NN ,_,
        fibrinogen-binding_JJ proteins_NNS [_NN 4_CD 5_CD 6_CD ]_NN ,_, elastin-binding_JJ
        adhesin_NN [_NN 7_CD ]_NN collagen-binding_JJ adhesion_NN [_NN 8_CD ]_NN ,_, and_CC a_DT
        broad-specificity_JJ adhesin_NN (_( MAP_NNP )_) that_WDT facilitates_NNS
        low-affinity_JJ binding_JJ of_IN 
        S_NNP ._. aureus_NN to_TO several_JJ proteins_NNS ,_,
        including_VBG osteopontin_NN ,_, collagen_NN ,_, bone_NN sialoprotein_NN ,_,
        fibronectin_NN ,_, fibrinogen_NN ,_, and_CC vitronectin_NN [_NN 9_CD ]_NN ._. 
        S_NNP ._. aureus_NN can_MD utilize_VB MSCRAMMs_NNP to_TO
        adhere_VB directly_RB to_TO cells_NNS or_CC can_MD attach_VB to_TO cells_NNS through_IN the_DT
        use_NN of_IN bridging_VBG ligands_NNS such_JJ as_IN Hsp_NNP 60_CD which_WDT has_VBZ an_DT affinity_NN
        for_IN both_DT MSCRAMMs_NNP and_CC the_DT β_NN 
        1_CD -_: integrin_NN host_NN cell_NN receptor_NN [_NN 10_CD 11_CD ]_NN
        ._. Interaction_NNP of_IN 
        S_NNP ._. aureus_NN with_IN host_NN cells_NNS via_IN
        MSCRAMMs_NNP can_MD induce_VB signal_NN transduction_NN ,_, tyrosine_NN kinase_NN
        activity_NN ,_, and_CC cytoskeletal_NN rearrangement_NN [_NN 12_CD ]_NN ._.
        Compared_VBN to_TO other_JJ bacteria_NNS ,_, 
        S_NNP ._. aureus_NN is_VBZ generally_RB not_RB considered_VBD
        a_DT significant_JJ intracellular_NN pathogen_NN ._. Staphylococci_NNP have_VBP
        typically_RB been_VBN regarded_VBN as_IN non-invasive_JJ extracellular_NN
        pathogens_NNS that_WDT damage_NN host_NN cells_NNS after_IN adhering_VBG to_TO the_DT
        extracellular_NN matrix_NN ;_: however_RB ,_, there_EX is_VBZ growing_VBG evidence_NN
        that_IN 
        S_NNP ._. aureus_NN has_VBZ the_DT ability_NN to_TO invade_VB
        and_CC persist_VB within_IN eukaryotic_JJ cells_NNS ._. 
        S_NNP ._. aureus_NN has_VBZ been_VBN shown_VBN to_TO be_VB
        ingested_JJ by_IN non-professional_JJ phagocytes_NNS ,_, such_JJ as_IN mouse_NN
        fibroblasts_NNS [_NN 13_CD ]_NN ,_, mouse_NN renal_JJ cells_NNS [_NN 14_CD ]_NN ,_, and_CC bovine_JJ
        mammary_JJ epithelial_NN cells_NNS [_NN 15_CD 16_CD ]_NN ._. 
        S_NNP ._. aureus_NN also_RB has_VBZ the_DT ability_NN to_TO
        invade_VB mouse_NN and_CC human_JJ osteoblast_NN cell_NN lines_NNS [_NN 17_CD 18_CD ]_NN ,_, as_RB
        well_RB as_IN normal_JJ mouse_NN and_CC human_JJ osteoblasts_NNS [_NN 19_CD ]_NN ._.
        Finally_RB ,_, 
        S_NNP ._. aureus_NN has_VBZ been_VBN shown_VBN to_TO invade_VB
        normal_JJ chick_NN osteoblasts_NNS both_DT in_IN vitro_NN and_CC in_IN vivo_NN [_NN 20_CD 21_CD
        ]_NN ._. 
        S_NNP ._. aureus_NN cells_NNS were_VBD found_VBN in_IN
        approximately_RB 14_CD %_NN of_IN calvarial_NN osteoblasts_NNS after_IN
        subcutaneous_JJ injection_NN of_IN chick_NN embryos_NNS ,_, and_CC in_IN 11_CD %_NN of_IN
        calvarial_NN and_CC tibial_NN osteoblasts_NNS following_VBG intra-allantoic_JJ
        injection_NN ._. Similar_JJ to_TO most_JJS in_IN vitro_NN studies_NNS ,_, the_DT majority_NN
        of_IN intracellular_NN bacteria_NNS are_VBP eventually_RB free_JJ in_IN the_DT
        osteoblast_NN cytoplasm_NN in_IN vivo_NN ._. 
        S_NNP ._. aureus_NN cells_NNS in_IN calvariae_NN and_CC
        tibiae_NN were_VBD also_RB observed_VBN in_IN the_DT cytoplasm_NN of_IN approximately_RB
        4_CD %_NN of_IN the_DT osteocytes_NNS in_IN mineralized_JJ bone_NN matrix_NN ._. Therefore_RB ,_,
        osteoblasts_NNS containing_VBG internalized_JJ 
        S_NNP ._. aureus_NN cells_NNS continue_VBP
        differentiating_VBG into_IN osteocytes_NNS ._. In_IN addition_NN ,_, 
        S_NNP ._. aureus_NN invasion_NN of_IN osteoblasts_NNS
        stimulates_NNS the_DT secretion_NN of_IN interleukin_NN (_( IL_NNP )_) -_: 6_CD ,_, IL-_NNP 12_CD ,_, and_CC
        colony-stimulating_JJ factors_NNS [_NN 19_CD 22_CD 23_CD ]_NN ._. These_DT cytokines_NNS
        can_MD potentially_RB exacerbate_VB the_DT bone_NN destruction_NN already_RB
        characteristic_NN of_IN infection_NN by_IN activation_NN of_IN osteoclasts_NNS ._.
        In_IN addition_NN to_TO osteoclast_NN activation_NN ,_, 
        S_NNP ._. aureus_NN inhibits_NNS bone-matrix_JJ
        synthesis_NN ,_, further_JJ compounding_NN bone_NN loss_NN observed_VBD with_IN
        osteomyelitis_NNS [_NN 24_CD ]_NN ._.
        The_DT ability_NN of_IN 
        S_NNP ._. aureus_NN to_TO survive_VB in_IN the_DT
        eukaryotic_JJ intracellular_NN environment_NN could_MD explain_VB several_JJ
        aspects_NNS of_IN chronic_JJ staphylococcal_NN diseases_NNS and_CC long-term_JJ
        colonization_NN ._. Internalization_NNP may_MD provide_VB a_DT means_NN of_IN
        protection_NN against_IN host_NN defenses_NNS and_CC certain_JJ classes_NNS of_IN
        antibiotics_NNS ._. Many_JJ staphylococcal_NN infections_NNS which_WDT tend_VBP to_TO
        become_VB chronic_JJ (_( e_SYM ._. g_SYM ._. ,_, osteomyelitis_NNS and_CC mastitis_NNS )_) are_VBP
        associated_VBN with_IN multiple_JJ recurrences_NNS and_CC do_VBP not_RB resolve_VB
        even_RB in_IN the_DT presence_NN of_IN what_WP seems_VBZ to_TO be_VB an_DT adequate_JJ
        humoral_NN immune_JJ response_NN [_NN 25_CD 26_CD 27_CD 28_CD ]_NN ._. For_IN example_NN ,_,
        patients_NNS can_MD have_VB recurrent_JJ attacks_NNS of_IN osteomyelitis_NNS after_IN
        completion_NN of_IN treatment_NN ,_, even_RB when_WRB causative_JJ organisms_NNS
        cannot_NN be_VB isolated_VBN [_NN 25_CD ]_NN ._.
        Staphylococcal_NNP infections_NNS are_VBP typically_RB associated_VBN with_IN
        death_NN of_IN tissue_NN ,_, and_CC evidence_NN suggests_VBZ intracellular_NN
        bacteria_NNS are_VBP capable_JJ of_IN inducing_VBG apoptosis_NNS ._. 
        S_NNP ._. aureus_NN -_: mediated_JJ apoptosis_NNS has_VBZ
        been_VBN reported_VBN in_IN epithelial_NN cells_NNS [_NN 16_CD 29_CD 30_CD ]_NN ,_,
        keratinocytes_NNS [_NN 31_CD ]_NN ,_, endothelial_NN cells_NNS [_NN 32_CD 33_CD ]_NN ,_, and_CC
        osteoblasts_NNS [_NN 34_CD ]_NN ._. The_DT two_CD global_JJ gene_NN regulatory_JJ loci_NN 
        agr_NN and_CC 
        sar_NN have_VBP been_VBN demonstrated_VBN to_TO play_VB a_DT
        role_NN in_IN the_DT induction_NN of_IN apoptosis_NNS in_IN epithelial_NN cells_NNS by_IN 
        S_NNP ._. aureus_NN [_NN 33_CD ]_NN ._. Mutants_NNP in_IN the_DT 
        agr_NN or_CC 
        sar_NN loci_NN are_VBP internalized_JJ ,_, but_CC do_VBP not_RB
        induce_VB apoptosis_NNS [_NN 33_CD ]_NN ._. Another_DT study_NN demonstrated_VBD
        induction_NN of_IN apoptosis_NNS in_IN endothelial_NN cells_NNS by_IN
        staphylococcal_NN alpha_NN toxin_NN [_NN 32_CD ]_NN ._.
        Wesson_NNP et_CC al_NN ._. [_NN 30_CD ]_NN demonstrated_VBD host_NN caspases-_NN 8_CD and_CC -_: 3_CD
        to_TO play_VB a_DT role_NN in_IN 
        S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS ,_, and_CC
        caspase-_NN 8_CD is_VBZ known_VBN to_TO be_VB associated_VBN with_IN apoptosis_NNS
        triggered_VBN by_IN engagement_NN of_IN death_NN receptors_NNS [_NN 35_CD ]_NN ._. Several_JJ
        recent_JJ studies_NNS have_VBP associated_VBN microbial_NN induction_NN of_IN
        apoptosis_NNS with_IN the_DT production_NN of_IN tumor_NN necrosis_NNS
        factor-related_JJ apoptosis-inducing_JJ ligand_NN (_( TRAIL_NNP )_) ._. Measles_NNP
        virus_NN was_VBD the_DT first_JJ infectious_JJ agent_NN shown_VBN to_TO induce_VB TRAIL_NNP
        production_NN [_NN 36_CD ]_NN ._. Other_JJ studies_NNS have_VBP demonstrated_VBN
        induction_NN of_IN TRAIL_NNP by_IN Theiler_NNP 's_POS murine_NN encephalomyelitis_NNS
        virus_NN (_( TMEV_NNP )_) in_IN M_NNP 1_CD -_: D_NNP cells_NNS (_( a_DT myelomonocytic_JJ precursor_NN cell_NN
        line_NN )_) [_NN 37_CD ]_NN ,_, reovirus_JJ infection_NN in_IN fibroblasts_NNS [_NN 38_CD ]_NN ,_,
        HIV-_NNP 1_CD infection_NN in_IN CD_NNP 4_CD +_NN T_NN cells_NNS [_NN 39_CD ]_NN ,_, and_CC adenovirus_JJ in_IN
        239_CD T_NN cells_NNS [_NN 40_CD ]_NN ._. The_DT demonstration_NN of_IN caspase-_NN 8_CD
        involvement_NN in_IN 
        S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS is_VBZ
        complemented_JJ by_IN a_DT recent_JJ report_NN from_IN our_PRP$ laboratory_NN that_IN 
        S_NNP ._. aureus_NN induces_VBZ expression_NN of_IN TRAIL_NNP
        by_IN infected_JJ osteoblasts_NNS [_NN 41_CD ]_NN ._. We_PRP reported_VBD that_IN 
        S_NNP ._. aureus_NN strongly_RB induces_VBZ TRAIL_NNP
        expression_NN by_IN both_DT normal_JJ mouse_NN and_CC normal_JJ human_JJ
        osteoblasts_NNS ,_, while_IN mRNAs_NNS encoding_VBG the_DT
        death-domain-containing_JJ TRAIL_NNP receptors_NNS are_VBP constitutively_RB
        expressed_VBN in_IN the_DT same_JJ cells_NNS ._. 
        S_NNP ._. aureus_NN caused_VBD a_DT rapid_JJ and_CC
        sustained_VBN up-regulation_JJ of_IN TRAIL_NNP mRNA_NN and_CC TRAIL_NNP protein_NN
        expression_NN ._. TRAIL_NNP is_VBZ also_RB secreted_JJ by_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS ,_,
        suggesting_VBG that_IN TRAIL_NNP could_MD influence_VB cells_NNS outside_IN the_DT
        environment_NN of_IN a_DT localized_JJ bacterial_JJ infection_NN ._.
        In_IN the_DT present_JJ study_NN ,_, we_PRP examined_VBD the_DT ability_NN of_IN
        purified_JJ bacterial_JJ surface_NN structures_NNS and_CC extracellular_NN
        products_NNS to_TO induce_VB TRAIL_NNP expression_NN in_IN osteoblasts_NNS ._. The_DT
        ability_NN of_IN TRAIL_NNP produced_VBN by_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS to_TO
        mediate_VB osteoblast_NN apoptosis_NNS was_VBD also_RB examined_VBN ._. Results_NNS
        demonstrate_VBP that_IN purified_JJ bacterial_JJ surface_NN structures_NNS and_CC 
        S_NNP ._. aureus_NN extracellular_NN products_NNS
        present_JJ outside_JJ osteoblasts_NNS are_VBP not_RB a_DT sufficient_JJ stimulus_NN
        for_IN TRAIL_NNP induction_NN ,_, and_CC that_IN physical_JJ contact_NN between_IN
        bacteria_NNS and_CC osteoblasts_NNS is_VBZ required_VBN for_IN optimal_NN induction_NN
        of_IN TRAIL_NNP expression_NN ._. TRAIL_NNP produced_VBN by_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS does_VBZ
        induce_VB caspase-_NN 8_CD activation_NN and_CC apoptosis_NNS ._. Collectively_RB ,_,
        these_DT results_NNS reveal_VBP TRAIL_NNP induction_NN and_CC caspase-_NN 8_CD
        activation_NN as_IN a_DT mechanism_NN whereby_WRB 
        S_NNP ._. aureus_NN mediates_NNS apoptosis_NNS in_IN
        osteoblasts_NNS ._.
      
      
        Results_NNS
        
          Purified_NNP bacterial_JJ products_NNS in_IN the_DT osteoblast_NN
          extracellular_NN environment_NN do_VBP not_RB induce_VB TRAIL_NNP
          expression_NN
          In_IN order_NN to_TO determine_VB the_DT role_NN of_IN 
          S_NNP ._. aureus-_NN derived_VBD peptidoglycan_NN
          and_CC teichoic_JJ acid_NN in_IN the_DT expression_NN of_IN TRAIL_NNP by_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS ,_,
          cultured_JJ normal_JJ human_JJ osteoblasts_NNS were_VBD incubated_JJ with_IN
          various_JJ concentrations_NNS of_IN these_DT purified_JJ cell_NN wall_NN
          structures_NNS (_( 10_CD ng_NN /_NN ml_NN ,_, 100_CD ng_NN /_NN ml_NN ,_, or_CC 1_CD μg_NN /_NN ml_NN )_) ._.
          Additionally_RB ,_, osteoblasts_NNS were_VBD incubated_JJ with_IN various_JJ
          concentrations_NNS of_IN staphylococcal_NN enterotoxin_NN A_DT (_( SEA_NNP ;_: 10_CD
          ng_NN /_NN ml_NN ,_, 100_CD ng_NN /_NN ml_NN ,_, or_CC 1_CD μg_NN /_NN ml_NN )_) ,_, used_VBD here_RB as_IN a_DT
          representative_NN superantigen_NN from_IN 
          S_NNP ._. aureus_NN ,_, or_CC with_IN a_DT purified_JJ
          component_NN of_IN gram-negative_JJ bacteria_NNS ,_, specifically_RB
          lipopolysaccharide_NN (_( LPS_NNP ;_: 10_CD ng_NN /_NN ml_NN ,_, 100_CD ng_NN /_NN ml_NN ,_, or_CC 1_CD
          μg_NN /_NN ml_NN )_) ._. The_DT concentrations_NNS of_IN staphylococcal_NN
          peptidoglycan_NN ,_, teichoic_JJ acid_NN ,_, SEA_NNP ,_, and_CC LPS_NNP tested_VBD did_VBD not_RB
          induce_VB TRAIL_NNP expression_NN in_IN osteoblasts_NNS (_( Fig_NNP ._. 1_LS )_) ._. Results_NNS
          for_IN the_DT lower_JJR concentrations_NNS of_IN teichoic_JJ acid_NN and_CC SEA_NNP (_( 10_CD
          ng_NN /_NN ml_NN and_CC 100_CD ng_NN /_NN ml_NN )_) are_VBP not_RB shown_VBN ._. As_IN previously_RB
          reported_VBD [_NN 41_CD ]_NN ,_, TRAIL_NNP protein_NN was_VBD induced_VBN in_IN
          osteoblasts_NNS infected_VBN with_IN 
          S_NNP ._. aureus_NN (_( Fig_NNP ._. 1_LS )_) ._. These_DT results_NNS
          demonstrate_VBP that_IN major_JJ surface_NN components_NNS from_IN these_DT
          bacteria_NNS in_IN a_DT purified_JJ form_NN ,_, present_JJ in_IN the_DT osteoblast_NN
          extracellular_NN environment_NN ,_, are_VBP not_RB sufficient_JJ to_TO induce_VB
          TRAIL_NNP expression_NN in_IN normal_JJ human_JJ osteoblasts_NNS ._.
        
        
          Induction_NNP of_IN TRAIL_NNP by_IN S_NNP ._. aureusrequires_NNS physical_JJ
          contact_NN between_IN bacteria_NNS and_CC osteoblasts_NNS
          Studies_NNS indicate_VBP that_IN the_DT invasion_NN ability_NN of_IN bacteria_NNS
          are_VBP most_RBS relevant_JJ to_TO the_DT magnitude_NN of_IN the_DT osteoblast_NN
          response_NN [_NN 42_CD 43_CD ]_NN ._. In_IN previous_JJ experiments_NNS examining_VBG
          the_DT production_NN of_IN TRAIL_NNP by_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS ,_,
          bacteria_NNS were_VBD in_IN direct_JJ contact_NN with_IN the_DT cells_NNS [_NN 41_CD ]_NN ,_,
          such_JJ that_IN the_DT potential_NN of_IN 
          S_NNP ._. aureus_NN extracellular_NN products_NNS to_TO
          induce_VB osteoblast_NN expression_NN and_CC secretion_NN of_IN TRAIL_NNP could_MD
          not_RB be_VB addressed_VBN ._. To_TO determine_VB if_IN 
          S_NNP ._. aureus_NN extracellular_NN products_NNS
          induce_VB TRAIL_NNP expression_NN in_IN osteoblasts_NNS ,_, normal_JJ mouse_NN
          osteoblasts_NNS were_VBD grown_VBN in_IN 12_CD -_: well_RB cluster_NN plates_NNS ._. 
          S_NNP ._. aureus_NN strain_NN UAMS-_NNP 1_CD at_IN a_DT MOI_NNP of_IN
          25_CD :_: 1_CD ,_, 75_CD :_: 1_CD ,_, or_CC 250_CD :_: 1_CD was_VBD then_RB added_VBN separately_RB to_TO
          Transwell_NNP ®_NN cell_NN culture_NN chamber_NN inserts_NNS ._. The_DT inserts_NNS were_VBD
          placed_VBN into_IN the_DT 12_CD -_: well_RB plates_NNS containing_VBG osteoblasts_NNS
          followed_VBN by_IN incubation_NN for_IN 45_CD minutes_NNS ._. The_DT polycarbonate_NN
          membrane_NN at_IN the_DT base_NN of_IN each_DT chamber_NN insert_NN contains_VBZ
          pores_VBZ 0_CD ._. 4_CD μm_NN in_IN size_NN ,_, and_CC precludes_VBZ direct_JJ interaction_NN
          between_IN the_DT bacteria_NNS and_CC osteoblasts_NNS ._. However_RB ,_, the_DT
          inserts_NNS allow_VBP for_IN the_DT exchange_NN of_IN extracellular_NN products_NNS ._.
          Direct_NNP physical_JJ contact_NN between_IN 
          S_NNP ._. aureus_NN and_CC osteoblasts_NNS at_IN a_DT MOI_NNP
          of_IN 250_CD :_: 1_CD induced_VBN osteoblast_NN TRAIL_NNP protein_NN expression_NN
          (_( Fig_NNP ._. 2_LS )_) ._. TRAIL_NNP protein_NN was_VBD not_RB expressed_VBN in_IN osteoblast_NN
          cultures_NNS co-incubated_JJ with_IN 
          S_NNP ._. aureus_NN at_IN various_JJ MOIs_NNP where_WRB
          physical_JJ contact_NN between_IN the_DT bacteria_NNS and_CC osteoblasts_NNS was_VBD
          prevented_VBN (_( Fig_NNP ._. 2_LS )_) ._. These_DT results_NNS demonstrate_VBP that_IN
          physical_JJ contact_NN between_IN the_DT host_NN and_CC pathogen_NN is_VBZ
          required_VBN for_IN optimal_NN TRAIL_NNP induction_NN ._. The_DT importance_NN of_IN
          bacterial_JJ internalization_NN ,_, however_RB ,_, could_MD not_RB be_VB
          addressed_VBN in_IN these_DT experiments_NNS ._.
        
        
          TRAIL_NNP induces_VBZ apoptosis_NNS in_IN osteoblasts_NNS
          TRAIL_NNP may_MD mediate_VB a_DT number_NN of_IN physiological_JJ responses_NNS ;_:
          therefore_RB ,_, in_IN order_NN to_TO determine_VB if_IN TRAIL_NNP expressed_VBN by_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS
          mediates_NNS osteoblast_NN apoptosis_NNS ,_, cultured_JJ normal_JJ mouse_NN
          osteoblasts_NNS were_VBD infected_VBN with_IN 
          S_NNP ._. aureus_NN strain_NN UAMS-_NNP 1_CD at_IN various_JJ
          MOIs_NNP in_IN the_DT presence_NN and_CC absence_NN of_IN an_DT anti-human_JJ TRAIL_NNP
          polyclonal_NN antibody_NN ._. Osteoblasts_NNP were_VBD stained_JJ with_IN
          annexin_NN V_NNP and_CC propidium_NN iodide_NN (_( PI_NNP )_) ._. Redistribution_NNP of_IN
          phosphotidylserine_NN from_IN the_DT inner_JJ leaflet_NN to_TO the_DT outer_JJ
          leaflet_NN of_IN the_DT plasma_NN membrane_NN occurs_VBZ early_JJ and_CC is_VBZ a_DT
          hallmark_NN of_IN the_DT apoptotic_JJ process_NN ._. Annexin_NNP V_NNP has_VBZ a_DT high_JJ
          affinity_NN for_IN phosphatidylserine_NN and_CC was_VBD used_VBN to_TO detect_VB
          apoptotic_JJ cells_NNS ._. Propidium_NNP iodide_NN can_MD be_VB used_VBN to_TO
          distinguish_VB early_JJ apoptotic_JJ cells_NNS from_IN late_JJ apoptotic_JJ
          cells_NNS ._. Early_RB apoptotic_JJ cells_NNS stain_VB positive_JJ for_IN annexin_NN V_NNP
          and_CC negative_JJ for_IN PI_NNP ,_, where_WRB as_IN late_JJ apoptotic_JJ cells_NNS stain_VB
          positive_JJ for_IN both_DT annexin_NN V_NNP and_CC PI_NNP [_NN 44_CD ]_NN ._. After_IN
          staining_VBG ,_, osteoblasts_NNS were_VBD analyzed_VBN using_VBG FACS_NNP (_( Fig_NNP ._. 3_LS )_) ._.
          Approximately_RB 14_CD ._. 89_CD %_NN of_IN the_DT cells_NNS from_IN uninfected_JJ
          osteoblast_NN cultures_NNS were_VBD annexin_NN V_NNP positive_NN ._. The_DT
          percentage_NN of_IN annexin_NN V-_NNP positive_JJ cells_NNS increased_VBN to_TO
          32_CD ._. 17_CD %_NN following_VBG infection_NN with_IN 
          S_NNP ._. aureus_NN at_IN a_DT MOI_NNP of_IN 75_CD :_: 1_CD ,_,
          corresponding_JJ to_TO a_DT greater_JJR than_IN 2_CD -_: fold_VB increase_NN over_IN that_DT
          of_IN uninfected_JJ control_NN osteoblast_NN cultures_NNS ._. A_DT 25_CD %_NN
          reduction_NN in_IN annexin_NN V-_NNP positive_JJ cells_NNS was_VBD observed_VBN in_IN the_DT
          presence_NN of_IN 1_CD μg_NN /_NN ml_NN of_IN anti-human_JJ TRAIL_NNP antibody_NN ._. A_DT 2_CD
          μg_NN /_NN ml_NN concentration_NN of_IN anti-_NN TRAIL_NNP antibody_NN further_RBR
          reduced_VBD the_DT population_NN of_IN annexin_NN V-_NNP positive_JJ cells_NNS to_TO
          25_CD ._. 42_CD %_NN of_IN total_JJ osteoblasts_NNS ,_, corresponding_JJ to_TO an_DT
          approximately_RB 40_CD %_NN decrease_NN in_IN the_DT level_NN of_IN annexin_NN
          V-_NNP positive_JJ cells_NNS in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ cultures_NNS ._. A_DT
          dose-dependent_JJ decrease_NN in_IN annexin_NN V-_NNP positive_JJ cells_NNS was_VBD
          observed_VBN by_IN the_DT addition_NN of_IN increasing_VBG amounts_NNS of_IN the_DT
          anti-human_JJ TRAIL_NNP antibody_NN ._. These_DT results_NNS strongly_RB suggest_VBP
          TRAIL_NNP production_NN induces_VBZ osteoblast_NN apoptosis_NNS in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblast_NN
          cultures_NNS ._. The_DT role_NN of_IN TRAIL_NNP in_IN 
          S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS is_VBZ
          likely_JJ more_RBR significant_JJ than_IN what_WP is_VBZ revealed_VBN by_IN these_DT
          experiments_NNS ,_, since_IN an_DT anti-human_JJ TRAIL_NNP antibody_NN was_VBD used_VBN
          to_TO neutralize_NN mouse_NN TRAIL_NNP protein_NN ._. Utilization_NN of_IN an_DT
          anti-mouse_JJ TRAIL_NNP antibody_NN would_MD be_VB predicted_VBN to_TO further_VB
          reduce_VB the_DT level_NN of_IN 
          S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS in_IN
          infected_JJ mouse_NN osteoblast_NN cultures_NNS ._.
        
        
          S_NNP ._. aureusinduces_NNS caspase-_NN 8_CD activation_NN in_IN
          osteoblasts_NNS
          
          S_NNP ._. aureus_NN -_: mediated_JJ apoptosis_NNS has_VBZ
          been_VBN reported_VBN for_IN a_DT variety_NN of_IN cells_NNS including_VBG
          osteoblasts_NNS ._. A_DT recent_JJ report_NN demonstrated_VBN that_IN 
          S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS of_IN
          epithelial_NN cells_NNS involves_VBZ activation_NN of_IN caspases-_NN 8_CD and-_NN 3_CD
          [_NN 30_CD ]_NN ._. To_TO determine_VB whether_IN caspase-_NN 8_CD is_VBZ activated_VBN in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS ,_,
          cultured_JJ normal_JJ mouse_NN osteoblasts_NNS were_VBD infected_VBN with_IN 
          S_NNP ._. aureus_NN strain_NN UAMS-_NNP 1_CD at_IN various_JJ
          MOIs_NNP ._. As_IN a_DT positive_JJ control_NN ,_, osteoblasts_NNS were_VBD stimulated_VBN
          with_IN cycloheximide_NN (_( CHX_NNP )_) ,_, a_DT compound_NN known_VBN to_TO induce_VB
          caspase-_NN 8_CD activation_NN [_NN 45_CD ]_NN ._. At_IN various_JJ times_NNS
          post-infection_JJ ,_, endogenous_JJ caspase-_NN 8_CD activity_NN was_VBD
          quantified_VBN ._.
          Activated_NNP caspase-_NN 8_CD was_VBD detected_VBN in_IN uninfected_JJ control_NN
          osteoblast_NN cultures_NNS (_( Fig_NNP ._. 4_LS )_) and_CC is_VBZ attributable_JJ to_TO
          apoptosis_NNS and_CC cell_NN turnover_NN in_IN the_DT in_IN vitro_NN osteoblast_NN
          tissue_NN culture_NN system_NN ._. Osteoblasts_NNP infected_VBN with_IN 
          S_NNP ._. aureus_NN at_IN a_DT MOI_NNP of_IN 75_CD :_: 1_CD
          demonstrated_VBD a_DT 2_CD -_: fold_VB increase_NN in_IN activated_VBN caspase-_NN 8_CD 45_CD
          min_NN post-infection_JJ ,_, which_WDT was_VBD significantly_RB higher_JJR than_IN
          the_DT level_NN of_IN activated_VBN caspase-_NN 8_CD in_IN the_DT uninfected_JJ
          control_NN (_( p_NN <_NN 0_CD ._. 05_CD )_) (_( Fig_NNP ._. 4_LS )_) ._. This_DT early_JJ activation_NN of_IN
          caspase-_NN 8_CD in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS
          coincides_VBZ with_IN previous_JJ observations_NNS in_IN other_JJ systems_NNS ._.
          For_IN example_NN ,_, caspase-_NN 8_CD is_VBZ activated_VBN in_IN HeLa_NNP cells_NNS within_IN
          1_CD h_NN following_VBG the_DT administration_NN of_IN TRAIL_NNP [_NN 46_CD ]_NN ._. The_DT
          level_NN of_IN caspase-_NN 8_CD activation_NN in_IN osteoblasts_NNS exposed_VBN to_TO
          CHX_NNP ,_, a_DT known_VBN activator_NN of_IN caspase-_NN 8_CD [_NN 45_CD ]_NN ,_, was_VBD
          significantly_RB higher_JJR than_IN the_DT level_NN of_IN activity_NN in_IN
          uninfected_JJ cells_NNS and_CC was_VBD equivalent_JJ to_TO the_DT level_NN in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS
          (_( Fig_NNP ._. 4_LS )_) ._. 
          S_NNP ._. aureus_NN -_: induced_VBN caspase-_NN 8_CD
          activation_NN was_VBD sustained_VBN for_IN 2_CD h_NN following_VBG infection_NN
          (_( data_NNS not_RB shown_VBN )_) ._. In_IN fact_NN ,_, the_DT levels_NNS of_IN activated_VBN
          caspase-_NN 8_CD were_VBD significantly_RB higher_JJR at_IN 2_CD h_NN than_IN at_IN 45_CD min_NN
          post-infection_JJ in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ
          osteoblasts_NNS ._.
          Caspase-_NNP 8_CD has_VBZ been_VBN identified_VBN as_IN an_DT initiator_NN caspase_NN
          activated_VBN in_IN death_NN receptor-mediated_JJ apoptosis_NNS [_NN 47_CD ]_NN ._.
          Therefore_RB ,_, we_PRP investigated_VBD whether_IN blockade_NN of_IN TRAIL_NNP
          expressed_VBN by_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS had_VBD
          any_DT effect_NN on_IN the_DT levels_NNS of_IN caspase-_NN 8_CD enzymatic_JJ activity_NN ._.
          Mouse_NNP osteoblasts_NNS were_VBD infected_VBN with_IN 
          S_NNP ._. aureus_NN in_IN the_DT presence_NN of_IN
          increasing_VBG concentrations_NNS of_IN anti-human-_JJ TRAIL_NNP antibody_NN ._.
          Figure_NN 4_CD demonstrates_VBZ that_DT anti-_NN TRAIL_NNP antibody_NN interferes_VBZ
          with_IN caspase-_NN 8_CD activation_NN ._. A_DT clear_JJ dose-response_JJ was_VBD
          observed_VBN in_IN the_DT levels_NNS of_IN caspase-_NN 8_CD enzymatic_JJ activity_NN ._.
          As_IN the_DT concentrations_NNS of_IN the_DT anti-_NN TRAIL_NNP antibody_NN
          increase_NN ,_, the_DT levels_NNS of_IN caspase-_NN 8_CD specific_JJ activity_NN
          decrease_NN ._. The_DT highest_JJS concentration_NN of_IN anti-_NN TRAIL_NNP
          antibody_NN utilized_JJ significantly_RB reduced_VBD the_DT level_NN of_IN
          caspase-_NN 8_CD enzymatic_JJ activity_NN in_IN 
          S_NNP ._. aureus_NN -_: infected_JJ osteoblast_NN
          cultures_NNS at_IN 45_CD min_NN and_CC 2_CD h_NN post-infection_JJ (_( p_NN <_NN 0_CD ._. 05_CD )_)
          (_( Fig_NNP ._. 4_LS and_CC data_NNS not_RB shown_VBN )_) ._. These_DT results_NNS suggest_VBP that_DT
          caspase-_NN 8_CD activation_NN is_VBZ mediated_JJ by_IN TRAIL_NNP ,_, and_CC that_DT
          induction_NN of_IN apoptosis_NNS by_IN TRAIL_NNP utilizes_NNS an_DT intracellular_NN
          mechanism_NN involving_VBG caspase-_NN 8_CD activation_NN ._.
        
      
      
        Discussion_NNP
        TRAIL_NNP is_VBZ a_DT member_NN of_IN the_DT TNF_NNP gene_NN superfamily_RB of_IN
        receptors_NNS and_CC ligands_NNS and_CC was_VBD discovered_VBN based_VBN on_IN sequence_NN
        homology_NN to_TO other_JJ members_NNS of_IN the_DT superfamily_RB using_VBG an_DT EST_NNP
        database_NN [_NN 48_CD ]_NN ._. Among_IN other_JJ family_NN members_NNS ,_, TRAIL_NNP is_VBZ most_RBS
        similar_JJ to_TO Fas_NNP ligand_NN ,_, sharing_VBG 28_CD %_NN homology_NN ._. TRAIL_NNP can_MD be_VB
        expressed_VBN as_IN a_DT membrane-bound_JJ protein_NN or_CC solubilized_JJ by_IN
        metalloendoproteinase_NN cleavage_NN ._. The_DT bioactive_JJ form_NN of_IN TRAIL_NNP
        is_VBZ as_IN a_DT homotrimer_NN [_NN 49_CD ]_NN ._. There_EX are_VBP five_CD known_VBN human_JJ
        TRAIL_NNP receptors_NNS ,_, including_VBG R_NN 1_CD ,_, R_NN 2_CD ,_, R_NN 3_CD ,_, R_NN 4_CD ,_, and_CC
        osteoprotegerin_NN (_( OPG_NNP )_) ;_: however_RB ,_, R_NN 1_CD and_CC R_NN 2_CD are_VBP the_DT only_RB
        TRAIL_NNP receptors_NNS known_VBN to_TO contain_VB complete_JJ death_NN domains_NNS ._.
        The_DT signaling_VBG pathways_NNS of_IN TRAIL_NNP and_CC its_PRP$ receptors_NNS are_VBP not_RB
        fully_RB known_VBN [_NN 50_CD ]_NN ;_: however_RB ,_, recent_JJ studies_NNS suggest_VBP TRAIL_NNP
        activates_NNS pathways_NNS similar_JJ to_TO those_DT activated_VBN by_IN TNF_NNP and_CC
        its_PRP$ receptors_NNS [_NN 49_CD ]_NN ._. Binding_NNP of_IN TRAIL_NNP to_TO death-domain_JJ
        containing_VBG receptors_NNS can_MD cause_VB apoptosis_NNS via_IN activation_NN of_IN
        caspase-_NN 8_CD in_IN Jurkat_NNP and_CC HeLa_NNP cells_NNS [_NN 46_CD 49_CD ]_NN ._.
        We_PRP have_VBP previously_RB demonstrated_VBN that_IN 
        S_NNP ._. aureus_NN induces_VBZ TRAIL_NNP expression_NN in_IN
        normal_JJ human_NN and_CC mouse_NN osteoblasts_NNS [_NN 41_CD ]_NN ._. Messenger_NNP RNA_NNP
        encoding_VBG TRAIL_NNP is_VBZ rapidly_RB and_CC dramatically_RB up-regulated_JJ
        following_NN exposure_NN of_IN osteoblasts_NNS to_TO 
        S_NNP ._. aureus_NN ._. TRAIL_NNP mRNA_NN expression_NN is_VBZ
        absent_JJ in_IN uninfected_JJ cultures_NNS and_CC shows_VBZ a_DT dose-dependent_JJ
        response_NN to_TO 
        S_NNP ._. aureus_NN ._. In_IN contrast_NN to_TO the_DT
        inducible_JJ nature_NN of_IN TRAIL_NNP mRNA_NN ,_, the_DT messages_NNS encoding_VBG
        death-domain-containing_JJ TRAIL_NNP receptors_NNS are_VBP constitutively_RB
        expressed_VBN in_IN human_NN and_CC mouse_NN osteoblasts_NNS [_NN 41_CD ]_NN ._.
        Additionally_RB ,_, TRAIL_NNP protein_NN is_VBZ expressed_VBN and_CC secreted_JJ
        following_NN infection_NN of_IN osteoblasts_NNS with_IN 
        S_NNP ._. aureus_NN ._. In_IN contrast_NN ,_, uninfected_JJ
        osteoblasts_NNS do_VBP not_RB express_VB significant_JJ amounts_NNS of_IN TRAIL_NNP
        protein_NN ._.
        The_DT current_JJ study_NN examined_VBD possible_JJ mechanisms_NNS whereby_WRB 
        S_NNP ._. aureus_NN induces_VBZ TRAIL_NNP expression_NN in_IN
        osteoblasts_NNS ._. Osteoblasts_NNP were_VBD incubated_JJ with_IN various_JJ
        concentrations_NNS of_IN major_JJ surface_NN components_NNS of_IN 
        S_NNP ._. aureus_NN ,_, peptidoglycan_NN and_CC
        teichoic_JJ acid_NN ,_, as_RB well_RB as_IN LPS_NNP of_IN gram-negative_JJ bacteria_NNS to_TO
        determine_VB if_IN these_DT were_VBD potential_JJ inducers_NNS of_IN TRAIL_NNP
        expression_NN ._. These_DT bacterial_JJ components_NNS were_VBD chosen_VBN based_VBN on_IN
        their_PRP$ ability_NN to_TO induce_VB inflammatory_JJ responses_NNS ._. The_DT two_CD
        major_JJ components_NNS of_IN the_DT staphylococcal_NN cell_NN wall_NN ,_,
        peptidoglycan_NN and_CC lipoteichoic_JJ acid_NN have_VBP been_VBN reported_VBN to_TO
        produce_VB inflammation_NN [_NN 51_CD 52_CD ]_NN and_CC specifically_RB to_TO induce_VB
        arthritis_NN [_NN 53_CD ]_NN ._. Bacterial_NNP peptidoglycan_NN is_VBZ also_RB known_VBN to_TO
        stimulate_VB the_DT bone-resorbing_JJ activity_NN of_IN macrophages_NNS [_NN 54_CD ]_NN
        ._. Furthermore_RB ,_, staphylococci_NN produce_VBP an_DT array_NN of_IN secreted_JJ
        products_NNS capable_JJ of_IN inducing_VBG or_CC sustaining_VBG inflammation_NN ._.
        For_IN example_NN ,_, the_DT staphylococcal_NN superantigens_NNS induce_VB
        prolonged_JJ inflammatory_JJ responses_NNS associated_VBN with_IN arthritis_NN
        and_CC destruction_NN of_IN bone_NN connective_JJ tissue_NN [_NN 55_CD ]_NN ._.
        Our_PRP$ results_NNS demonstrate_VBP that_DT peptidoglycan_NN ,_, teichoic_JJ
        acid_NN ,_, LPS_NNP ,_, and_CC the_DT staphylococcal_NN superantigen_NN
        staphylococcal_NN enterotoxin_NN A_DT (_( SEA_NNP )_) ,_, when_WRB present_JJ in_IN the_DT
        osteoblast_NN extracellular_NN environment_NN ,_, do_VBP not_RB induce_VB TRAIL_NNP
        expression_NN (_( Fig_NNP ._. 1_LS )_) ._. These_DT findings_NNS do_VBP not_RB eliminate_VB the_DT
        possibility_NN that_IN these_DT bacterial_JJ structures_NNS contribute_VBP to_TO
        TRAIL_NNP induction_NN ._. They_PRP are_VBP nevertheless_RB insufficient_JJ by_IN
        themselves_PRP to_TO elicit_NN such_JJ a_DT response_NN in_IN osteoblasts_NNS exposed_VBN
        extracellularly_RB to_TO the_DT molecules_NNS at_IN the_DT concentrations_NNS
        analyzed_VBD ._. The_DT concentrations_NNS of_IN bacterial_JJ products_NNS chosen_VBN
        were_VBD based_VBN on_IN previous_JJ reports_NNS suggesting_VBG these_DT amounts_NNS are_VBP
        appropriate_JJ and_CC sufficient_JJ to_TO elicit_NN cytokine_NN responses_NNS
        from_IN human_JJ cells_NNS [_NN 56_CD 57_CD ]_NN ._. It_PRP is_VBZ possible_JJ that_IN one_CD or_CC
        more_JJR of_IN the_DT purified_JJ products_NNS analyzed_VBD contribute_VB to_TO TRAIL_NNP
        induction_NN ,_, but_CC only_RB if_IN expressed_VBD inside_IN osteoblasts_NNS ._.
        While_IN intracellular_NN 
        S_NNP ._. aureus_NN is_VBZ known_VBN to_TO induce_VB TRAIL_NNP
        expression_NN in_IN osteoblasts_NNS [_NN 41_CD ]_NN ,_, the_DT ability_NN of_IN
        extracellular_NN staphylococcal_NN products_NNS to_TO induce_VB TRAIL_NNP
        expression_NN has_VBZ not_RB been_VBN previously_RB investigated_VBN ._. Results_NNS
        from_IN the_DT Transwell_NNP ®_NN co-culture_JJ experiments_NNS (_( Fig_NNP ._. 2_LS )_)
        demonstrate_VB that_DT extracellular_NN bacterial_JJ products_NNS do_VBP not_RB
        induce_VB TRAIL_NNP expression_NN ._. 
        S_NNP ._. aureus_NN at_IN a_DT MOI_NNP of_IN 25_CD :_: 1_CD ,_, 75_CD :_: 1_CD ,_, or_CC
        250_CD :_: 1_CD was_VBD unable_JJ to_TO induce_VB TRAIL_NNP expression_NN when_WRB direct_JJ
        contact_NN between_IN bacteria_NNS and_CC osteoblasts_NNS was_VBD precluded_VBN ._.
        Even_RB at_IN the_DT highest_JJS MOI_NNP used_VBD ,_, no_DT TRAIL_NNP was_VBD detected_VBN in_IN
        response_NN to_TO the_DT co-incubation_JJ with_IN 
        S_NNP ._. aureus_NN ._. The_DT bacteria_NNS must_MD be_VB in_IN
        physical_JJ contact_NN ,_, and_CC potentially_RB internalized_JJ by_IN the_DT
        osteoblasts_NNS ,_, before_IN TRAIL_NNP expression_NN is_VBZ induced_VBN ._. These_DT
        findings_NNS could_MD indicate_VB that_DT attachment_NN of_IN 
        S_NNP ._. aureus_NN to_TO osteoblasts_NNS initiates_NNS a_DT
        cascade_NN ultimately_RB inducing_VBG TRAIL_NNP expression_NN ._.
        Alternatively_RB ,_, intracellular_NN bacteria_NNS may_MD be_VB the_DT only_RB 
        S_NNP ._. aureus_NN cells_NNS capable_JJ of_IN inducing_VBG
        TRAIL_NNP expression_NN by_IN osteoblasts_NNS ._.
        TRAIL_NNP clearly_RB mediates_NNS cell_NN death_NN in_IN other_JJ tissues_NNS ,_, but_CC
        also_RB has_VBZ the_DT potential_NN to_TO mediate_VB a_DT variety_NN of_IN other_JJ
        physiological_JJ responses_NNS in_IN bone_NN ._. Osteoblasts_NNP are_VBP known_VBN to_TO
        secrete_NN tumor_NN necrosis_NNS factor-related_JJ activation-induced_JJ
        cytokine_NN (_( TRANCE_NNP )_) (_( RANK-L_NNP )_) ,_, which_WDT acts_VBZ on_IN the_DT TRANCE_NNP
        receptor_NN (_( TRANCE-R_NNP )_) (_( RANK_NNP )_) found_VBD on_IN osteoclast_NN precursors_NNS ._.
        Binding_NNP of_IN TRANCE_NNP to_TO TRANCE-R_NNP induces_VBZ osteoclastogenesis_NNS
        and_CC therefore_RB bone_NN resorption_NN ._. Osteoblasts_NNP are_VBP also_RB known_VBN
        to_TO secrete_NN osteoprotegerin_NN (_( OPG_NNP )_) ,_, which_WDT binds_NNS TRANCE_NNP ,_, thus_RB
        inhibiting_VBG osteoclastogenesis_NNS ._. Because_IN OPG_NNP is_VBZ a_DT soluble_JJ
        receptor_NN for_IN TRAIL_NNP [_NN 58_CD ]_NN ,_, 
        S_NNP ._. aureus_NN -_: induced_VBN TRAIL_NNP secretion_NN
        could_MD have_VB a_DT profound_JJ effect_NN on_IN both_DT osteoblasts_NNS and_CC
        osteoclasts_NNS ._. Therefore_RB ,_, the_DT ability_NN of_IN TRAIL_NNP expressed_VBN by_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS to_TO
        mediate_VB osteoblast_NN apoptosis_NNS was_VBD examined_VBN ._.
        
        S_NNP ._. aureus_NN induces_VBZ osteoblast_NN
        apoptosis_NNS [_NN 34_CD ]_NN ._. When_WRB osteoblasts_NNS were_VBD exposed_VBN to_TO 
        S_NNP ._. aureus_NN at_IN a_DT MOI_NNP of_IN 75_CD :_: 1_CD ,_, the_DT
        percentages_NNS of_IN annexin_NN V-_NNP positive_JJ cells_NNS increased_VBN from_IN
        14_CD ._. 89_CD %_NN to_TO 32_CD ._. 17_CD %_NN of_IN cells_NNS in_IN culture_NN (_( Fig_NNP ._. 3_LS )_) ._. Numbers_NNPS of_IN
        annexin_NN V-_NNP positive_JJ cells_NNS were_VBD reduced_VBN 40_CD %_NN by_IN the_DT addition_NN
        of_IN anti-_NN TRAIL_NNP antibody_NN (_( 2_CD μg_NN /_NN ml_NN )_) to_TO 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblast_NN
        cultures_NNS ._. While_IN the_DT antibodies_NNS did_VBD not_RB completely_RB inhibit_VB 
        S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS ,_, these_DT
        results_NNS demonstrate_VBP that_IN TRAIL_NNP contributes_VBZ to_TO apoptosis_NNS in_IN 
        S_NNP ._. aureus_NN -_: infected_JJ cultures_NNS ._.
        TRAIL-mediated_NNP apoptosis_NNS of_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS
        suggests_VBZ a_DT mechanism_NN whereby_WRB 
        S_NNP ._. aureus_NN induces_VBZ the_DT bone_NN loss_NN and_CC
        destruction_NN associated_VBN with_IN osteomyelitis_NNS ._. The_DT inability_NN of_IN
        the_DT anti-_NN TRAIL_NNP antibodies_NNS to_TO completely_RB block_VB apoptosis_NNS
        induced_VBN by_IN 
        S_NNP ._. aureus_NN may_MD be_VB attributable_JJ to_TO the_DT
        specificity_NN of_IN the_DT antibody_NN used_VBN for_IN these_DT experiments_NNS or_CC
        the_DT dosage_NN used_VBD ,_, since_IN an_DT anti-human_JJ TRAIL_NNP antibody_NN was_VBD
        used_VBN to_TO neutralize_NN mouse_NN TRAIL_NNP protein_NN ._. The_DT role_NN of_IN TRAIL_NNP
        in_IN 
        S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS is_VBZ
        therefore_RB likely_JJ to_TO be_VB more_RBR significant_JJ than_IN what_WP is_VBZ
        revealed_VBN by_IN these_DT experiments_NNS ._. Utilization_NN of_IN an_DT anti-mouse_JJ
        TRAIL_NNP antibody_NN would_MD be_VB predicted_VBN to_TO be_VB more_RBR effective_JJ in_IN
        reducing_VBG the_DT level_NN of_IN 
        S_NNP ._. aureus_NN -_: induced_VBN apoptosis_NNS in_IN
        infected_JJ mouse_NN osteoblast_NN cultures_NNS ._. In_IN addition_NN ,_, 
        S_NNP ._. aureus_NN may_MD also_RB induce_VB apoptosis_NNS
        by_IN a_DT mechanism_NN distinct_JJ from_IN TRAIL_NNP ._. It_PRP is_VBZ known_VBN ,_, for_IN
        example_NN ,_, that_IN 
        S_NNP ._. aureus_NN α-toxin_JJ induces_VBZ apoptosis_NNS
        in_IN Jurkat_NNP cells_NNS via_IN the_DT Bcl-_NNP 2_CD -_: controlled_VBN mitochondrial_NN
        death_NN pathway_NN [_NN 32_CD ]_NN ;_: therefore_RB ,_, neutralization_NN of_IN TRAIL_NNP
        would_MD not_RB be_VB expected_VBN to_TO interfere_VB with_IN this_DT mechanism_NN of_IN
        apoptosis_NNS induction_NN ._.
        TRAIL-induced_NNP apoptosis_NNS involves_VBZ activation_NN of_IN caspase-_NN 8_CD
        in_IN other_JJ systems_NNS ._. Earlier_JJR studies_NNS have_VBP shown_VBN that_DT blockade_NN
        of_IN caspase-_NN 8_CD activation_NN in_IN HeLa_NNP cells_NNS and_CC deletion_NN of_IN
        caspase-_NN 8_CD in_IN Jurkat_NNP cells_NNS prevented_VBD activation_NN of_IN
        downstream_JJ signaling_VBG ,_, resulting_VBG in_IN a_DT failure_NN of_IN the_DT cells_NNS
        to_TO undergo_VB apoptosis_NNS in_IN response_NN to_TO TRAIL_NNP [_NN 46_CD ]_NN ._.
        Similarly_RB ,_, another_DT group_NN has_VBZ demonstrated_VBN that_IN apoptosis_NNS
        induced_VBN by_IN 
        S_NNP ._. aureus_NN in_IN bovine_JJ mammary_JJ
        epithelial_NN (_( MAC-T_NNP )_) cells_NNS utilizes_NNS a_DT mechanism_NN involving_VBG
        caspases-_NN 8_CD and_CC -_: 3_CD ,_, which_WDT are_VBP two_CD key_JJ components_NNS of_IN the_DT
        proteolytic_JJ cascade_NN that_WDT leads_VBZ to_TO apoptosis_NNS [_NN 30_CD ]_NN ._.
        Results_NNS from_IN the_DT current_JJ study_NN demonstrate_VBP a_DT two-fold_JJ
        increase_NN in_IN caspase-_NN 8_CD activation_NN upon_IN infection_NN with_IN 
        S_NNP ._. aureus_NN (_( Fig_NNP ._. 4_LS )_) ._. Active_JJ caspase-_NN 8_CD
        was_VBD detected_VBN in_IN uninfected_JJ control_NN osteoblast_NN cultures_NNS
        (_( Fig_NNP ._. 4_LS )_) ,_, and_CC is_VBZ attributable_JJ to_TO apoptosis_NNS and_CC cell_NN
        turnover_NN in_IN the_DT in_IN vitro_NN osteoblast_NN tissue_NN culture_NN systems_NNS ._.
        The_DT level_NN of_IN activated_VBN caspase-_NN 8_CD in_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS was_VBD
        significantly_RB higher_JJR than_IN the_DT level_NN of_IN activated_VBN caspase-_NN 8_CD
        in_IN uninfected_JJ osteoblast_NN control_NN cultures_NNS (_( p_NN <_NN 0_CD ._. 05_CD )_) ._.
        Caspase-_NNP 8_CD activation_NN in_IN osteoblasts_NNS exposed_VBN to_TO CHX_NNP was_VBD also_RB
        higher_JJR than_IN the_DT level_NN of_IN activity_NN in_IN uninfected_JJ cells_NNS ,_, but_CC
        equivalent_JJ to_TO the_DT level_NN in_IN infected_JJ osteoblasts_NNS (_( Fig_NNP ._. 4_LS )_) ._.
        These_DT results_NNS demonstrate_VBP that_IN 
        S_NNP ._. aureus_NN is_VBZ a_DT potent_JJ inducer_NN of_IN
        caspase-_NN 8_CD activation_NN in_IN osteoblasts_NNS ,_, equivalent_JJ to_TO a_DT known_VBN
        inducer_NN of_IN caspase-_NN 8_CD [_NN 45_CD ]_NN ._. Overall_RB ,_, the_DT levels_NNS of_IN
        caspase-_NN 8_CD enzymatic_JJ activity_NN at_IN 2_CD h_NN were_VBD significantly_RB
        higher_JJR compared_VBN to_TO the_DT ones_NNS obtained_VBD 45_CD min_NN post-infection_JJ
        (_( data_NNS not_RB shown_VBN )_) ._. Neutralization_NNP of_IN TRAIL_NNP by_IN the_DT addition_NN
        of_IN the_DT anti-_NN TRAIL_NNP antibody_NN interfered_VBD with_IN caspase-_NN 8_CD
        activation_NN ,_, demonstrating_VBG a_DT dose-dependent_JJ response_NN ._. As_IN the_DT
        concentrations_NNS of_IN the_DT anti-_NN TRAIL_NNP antibody_NN increased_VBD ,_, the_DT
        levels_NNS of_IN caspase-_NN 8_CD activation_NN decreased_VBD ._. The_DT highest_JJS
        concentration_NN of_IN antibodies_NNS used_VBN significantly_RB reduced_VBD the_DT
        level_NN of_IN caspase-_NN 8_CD activation_NN in_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblast_NN
        cultures_NNS (_( p_NN <_NN 0_CD ._. 05_CD )_) ._. These_DT findings_NNS demonstrate_VBP that_DT
        activation_NN of_IN caspase-_NN 8_CD in_IN 
        S_NNP ._. aureus_NN -_: infected_JJ osteoblasts_NNS is_VBZ at_IN
        least_JJS in_IN part_NN TRAIL-dependent_NNP ._.
      
      
        Conclusions_NNP
        Collectively_RB ,_, these_DT findings_NNS reveal_VBP that_IN 
        S_NNP ._. aureus_NN induces_VBZ apoptosis_NNS in_IN
        osteoblasts_NNS via_IN a_DT mechanism_NN involving_VBG TRAIL_NNP induction_NN and_CC
        caspase-_NN 8_CD activation_NN ._. Induction_NNP of_IN TRAIL_NNP by_IN 
        S_NNP ._. aureus_NN requires_VBZ the_DT bacteria_NNS to_TO be_VB
        in_IN contact_NN with_IN and_CC potentially_RB internalized_JJ by_IN the_DT
        osteoblasts_NNS ._. Although_IN the_DT exact_JJ mechanism_NN whereby_WRB 
        S_NNP ._. aureus_NN induces_VBZ TRAIL_NNP expression_NN
        remains_VBZ to_TO be_VB determined_VBN ,_, this_DT study_NN suggests_VBZ that_IN major_JJ
        bacterial_JJ surface_NN structures_NNS present_JJ in_IN the_DT osteoblast_NN
        extracellular_NN environment_NN do_VBP not_RB induce_VB TRAIL_NNP ._. Since_IN TRAIL_NNP
        mediates_NNS a_DT number_NN of_IN physiological_JJ responses_NNS ,_, the_DT impact_NN of_IN
        
        S_NNP ._. aureus_NN -_: induced_VBN TRAIL_NNP expression_NN
        on_IN normal_JJ bone_NN physiology_NN should_MD be_VB explored_JJ ._. The_DT role_NN of_IN 
        S_NNP ._. aureus_NN -_: induced_VBN TRAIL_NNP in_IN apoptosis_NNS
        and_CC osteoclastogenesis_NNS in_IN vivo_NN is_VBZ currently_RB being_VBG
        examined_VBN ._.
      
      
        Methods_NNP
        
          Normal_NNP mouse_NN osteoblast_NN cell_NN culture_NN
          Normal_NNP osteoblast_NN cell_NN cultures_NNS were_VBD prepared_VBN from_IN
          mouse_NN neonates_NNS according_VBG to_TO a_DT method_NN previously_RB described_VBD
          for_IN chicken_NN embryos_NNS [_NN 59_CD ]_NN ._. Bone-forming_NNP cells_NNS were_VBD
          isolated_VBN from_IN mouse_NN neonate_NN calvariae_NN by_IN sequential_NN
          collagenase_NN and_CC protease_NN digestions_NNS ._. The_DT periostea_NN were_VBD
          removed_VBN ,_, the_DT frontal_JJ bones_NNS were_VBD harvested_VBN free_JJ of_IN the_DT
          suture_NN regions_NNS ,_, and_CC the_DT bones_NNS were_VBD incubated_JJ for_IN 10_CD min_NN
          at_IN 37_CD °_NN C_NNP in_IN 10_CD ml_NN of_IN digestion_NN medium_NN ,_, containing_VBG
          collagenase_NN (_( 375_CD U_NNP /_NN ml_NN ,_, type_NN VII_NNP ;_: Sigma_NNP Chemical_NNP Company_NNP ,_,
          St_NNP ._. Louis_NNP ,_, Mo_NNP ._. )_) and_CC protease_NN (_( 7_CD ._. 5_LS U_NNP /_NN ml_NN ;_: Sigma_NNP )_) ._. The_DT
          digestion_NN medium_NN and_CC released_VBN cells_NNS were_VBD removed_VBN and_CC
          discarded_VBN ._. Ten_CD milliliters_NNS of_IN fresh_JJ digestion_NN medium_NN was_VBD
          added_VBN ,_, and_CC incubation_NN was_VBD continued_VBN for_IN 20_CD min_NN ._. Cells_NNP
          were_VBD harvested_VBN by_IN centrifugation_NN and_CC rinsed_JJ 3_CD times_NNS in_IN 25_CD
          mM_NN HEPES-buffered_NNP Hanks_NNP '_POS balanced_JJ salt_NN solution_NN (_( pH_NN 7_CD ._. 4_CD ;_:
          HBSS_NNP )_) ._. The_DT digestion_NN step_NN was_VBD repeated_VBN twice_RB ,_, and_CC the_DT 3_CD
          cell_NN isolates_VBZ were_VBD pooled_VBN in_IN mouse_NN osteoblast_NN growth_NN
          medium_NN (_( OBGM_NNP )_) ,_, consisting_VBG of_IN Dulbecco_NNP 's_POS modified_VBN Eagle_NNP 's_POS
          medium_NN containing_VBG 25_CD mM_NN HEPES_NNP ,_, 10_CD %_NN fetal_JJ bovine_JJ serum_NN
          (_( Sigma_NNP )_) ,_, 2_CD g_SYM of_IN sodium_NN bicarbonate_NN per_IN liter_NN ,_, 75_CD μg_NN of_IN
          glycine_NN /_NN ml_NN ,_, 100_CD μg_NN of_IN ascorbic_JJ acid_NN /_NN ml_NN ,_, 40_CD ng_NN of_IN vitamin_NN
          B_NNP 
          12_CD /_NN ml_NN ,_, 2_CD μg_NN of_IN 
          p_NN -_: aminobenzoic_JJ acid_NN /_NN ml_NN ,_, 200_CD ng_NN of_IN
          biotin_NN /_NN ml_NN ,_, and_CC penicillin_NN (_( 100_CD U_NNP /_NN ml_NN )_) -_: streptomycin_NN (_( 100_CD
          μg_NN /_NN ml_NN )_) -_: amphotericin_NN B_NNP (_( 25_CD μg_NN /_NN ml_NN )_) (_( pH_NN 7_CD ._. 4_LS )_) [_NN 60_CD ]_NN ._. Cells_NNP
          were_VBD seeded_VBN in_IN six-well_JJ cluster_NN plates_NNS and_CC incubated_JJ at_IN
          37_CD °_NN C_NNP in_IN a_DT 5_CD %_NN CO_NNP 
          2_CD atmosphere_NN until_IN they_PRP reached_VBD
          confluence_NN (_( 6_CD to_TO 7_CD days_NNS )_) ._.
        
        
          Characterization_NNP of_IN normal_JJ mouse_NN osteoblasts_NNS
          Mouse_NNP osteoblasts_NNS were_VBD grown_VBN on_IN glass_NN coverslips_NNS in_IN
          24_CD -_: well_RB plates_NNS until_IN they_PRP were_VBD confluent_NN ;_: they_PRP were_VBD then_RB
          fixed_VBN and_CC permeabilized_JJ using_VBG CytoFix_NNP /_NN CytoPerm_NNP according_VBG
          to_TO the_DT methods_NNS recommended_VBN by_IN the_DT manufacturer_NN
          (_( PharMingen_NNP ,_, San_NNP Diego_NNP ,_, Calif_NNP ._. )_) ._. Rabbit_NNP antibodies_NNS
          specific_JJ for_IN osteocalcin_NN (_( 1_CD :_: 100_CD dilution_NN ;_: Peninsula_NNP
          Laboratories_NNPS ,_, Belmont_NNP ,_, Calif_NNP ._. )_) ,_, type_NN I_PRP collagen_NN (_( 1_CD :_: 40_CD
          dilution_NN ;_: Chemicon_NNP ,_, Temecula_NNP ,_, Calif_NNP ._. )_) ,_, alkaline_NN
          phosphatase_NN (_( 1_CD :_: 40_CD dilution_NN ;_: Sigma_NNP )_) ,_, or_CC keyhole_NN limpet_NN
          hemocyanin_NN (_( 1_CD :_: 40_CD dilution_NN )_) were_VBD incubated_JJ on_IN cell_NN
          preparations_NNS for_IN 45_CD min_NN at_IN 4_CD °_NN C_NNP ._. After_IN unbound_NN antibody_NN
          was_VBD washed_VBN off_RP ,_, a_DT phycoerythrin-conjugated_JJ goat_NN
          anti-rabbit_JJ immunoglobulin_NN G_NNP antibody_NN (_( 1_CD :_: 50_CD dilution_NN ;_:
          Sigma_NNP )_) was_VBD added_VBN with_IN incubation_NN for_IN 45_CD min_NN at_IN 4_CD °_NN C_NNP ._. After_IN
          the_DT samples_NNS were_VBD washed_VBN ,_, at_IN least_JJS 500_CD cells_NNS were_VBD scored_VBN
          for_IN positive_JJ fluorescence_NN using_VBG an_DT Olympus_NNP BX_NNP 60_CD
          fluorescence_NN microscope_NN ._. Osteocalcin_NNP ,_, type_NN I_PRP collagen_NN ,_,
          and_CC alkaline_NN phosphatase_NN were_VBD selected_VBN for_IN analysis_NN ,_,
          since_IN the_DT expression_NN of_IN these_DT proteins_NNS has_VBZ been_VBN used_VBN to_TO
          define_VB osteoblasts_NNS as_IN such_JJ [_NN 61_CD 62_CD 63_CD ]_NN ._.
        
        
          Normal_NNP human_JJ osteoblast_NN cultures_NNS
          Normal_NNP human_JJ osteoblasts_NNS (_( Clonetics_NNP ,_, San_NNP Diego_NNP ,_,
          Calif_NNP ._. )_) were_VBD propagated_JJ according_VBG to_TO the_DT guidelines_NNS
          provided_VBN by_IN the_DT vendor_NN ._. Cells_NNP were_VBD seeded_VBN in_IN 25_CD -_: cm_NN
          2_CD flasks_NNS and_CC incubated_JJ at_IN 37_CD °_NN C_NNP in_IN a_DT 5_CD %_NN CO_NNP 
          2_CD atmosphere_NN in_IN medium_NN supplied_VBN by_IN the_DT
          manufacturer_NN ;_: this_DT medium_NN contains_VBZ 10_CD %_NN fetal_JJ bovine_JJ
          serum_NN ,_, ascorbic_JJ acid_NN ,_, and_CC gentamicin_NN ._. After_IN the_DT cells_NNS
          reached_VBN approximately_RB 80_CD %_NN confluence_NN (_( 5_CD to_TO 9_CD days_NNS )_) ,_, they_PRP
          were_VBD removed_VBN from_IN flasks_NNS with_IN 0_CD ._. 025_CD %_NN trypsin-_NN 0_CD ._. 01_CD %_NN EDTA_NNP ,_,
          washed_VBN in_IN medium_NN ,_, and_CC seeded_VBN into_IN six-well_JJ plates_NNS ._. Cells_NNP
          were_VBD used_VBN as_IN described_VBN below_IN once_RB they_PRP reached_VBD
          approximately_RB 80_CD %_NN confluence_NN (_( 6_CD to_TO 7_CD days_NNS )_) ._. These_DT
          commercially_RB available_JJ cells_NNS have_VBP been_VBN extensively_RB
          characterized_VBN as_IN osteoblasts_NNS [_NN 61_CD 64_CD ]_NN ._.
        
        
          Bacterial_NNP strain_NN and_CC growth_NN conditions_NNS
          
          S_NNP ._. aureus_NN strain_NN UAMS-_NNP 1_CD (_( ATCC_NNP
          49230_CD )_) (_( osteomyelitis_NNS clinical_JJ isolate_VB )_) was_VBD grown_VBN
          overnight_JJ in_IN 5_CD ml_NN of_IN tryptic_JJ soy_NN broth_NN at_IN 37_CD °_NN C_NNP with_IN
          aeration_NN ._. Bacteria_NNP were_VBD harvested_VBN by_IN centrifugation_NN for_IN
          10_CD min_NN at_IN 4_CD ,_, 300_CD ×_NN 
          g_SYM at_IN 4_CD °_NN C_NNP and_CC washed_VBN in_IN 5_CD ml_NN of_IN
          HBSS_NNP ._. Bacteria_NNP were_VBD then_RB resuspended_JJ in_IN mouse_NN OBGM_NNP ._.
        
        
          Infection_NNP and_CC invasion_NN assay_NN
          Following_VBG resuspension_NN of_IN bacteria_NNS in_IN OBGM_NNP ,_, bacterial_JJ
          cell_NN density_NN was_VBD determined_VBN via_IN spectrophotometric_JJ
          analysis_NN ._. Cells_NNP were_VBD then_RB diluted_VBN in_IN OBGM_NNP to_TO obtain_VB the_DT
          desired_VBN multiplicity_NN of_IN infection_NN (_( MOI_NNP )_) ._. Osteoblasts_NNP were_VBD
          infected_VBN with_IN 
          S_NNP ._. aureus_NN at_IN a_DT MOI_NNP of_IN 25_CD :_: 1_CD ,_, 75_CD :_: 1_CD ,_,
          or_CC 250_CD :_: 1_CD (_( 
          S_NNP ._. aureus_NN organisms_NNS to_TO
          osteoblasts_NNS )_) ._. The_DT highest_JJS MOIs_NNP used_VBD resulted_VBD in_IN
          approximately_RB one_CD internalized_JJ bacterium_NN per_IN osteoblast_NN
          in_IN culture_NN (_( data_NNS not_RB shown_VBN )_) ._. Following_VBG a_DT 45_CD min_NN
          infection_NN ,_, osteoblasts_NNS were_VBD washed_VBN three_CD times_NNS with_IN HBSS_NNP
          and_CC incubated_JJ in_IN medium_NN containing_VBG 25_CD μg_NN of_IN gentamicin_NN
          per_IN ml_NN to_TO kill_VB extracellular_NN bacteria_NNS ._. At_IN various_JJ times_NNS
          following_VBG bacterial_JJ invasion_NN ,_, osteoblasts_NNS were_VBD lysed_JJ and_CC
          total_JJ osteoblast_NN protein_NN isolated_VBN for_IN further_JJ
          analysis_NN ._.
        
        
          Osteoblast_NNP lysis_NNS and_CC protein_NN isolation_NN
          Osteoblasts_NNP were_VBD washed_VBN twice_RB with_IN phosphate-buffered_JJ
          saline_NN (_( PBS_NNP )_) pH_NN 7_CD ._. 4_CD ._. One_CD ml_NN of_IN PBS_NNP was_VBD then_RB added_VBN to_TO each_DT
          tissue_NN culture_NN well_RB and_CC osteoblasts_NNS were_VBD harvested_VBN by_IN
          scraping_VBG ._. Osteoblasts_NNP in_IN PBS_NNP were_VBD transferred_VBN to_TO
          microcentrifuge_NN tubes_NNS and_CC collected_VBN by_IN centrifugation_NN at_IN
          13_CD ,_, 600_CD ×_NN 
          g_SYM for_IN 3_CD min_NN at_IN 4_CD °_NN C_NNP using_VBG a_DT Fisher_NNP
          Scientific_NNP Micro-_NNP Centrifuge_NNP ._. Pellets_NNP were_VBD washed_VBN with_IN 1_CD
          ml_NN of_IN PBS_NNP and_CC then_RB resuspended_JJ in_IN 100_CD μl_NN of_IN whole_JJ extract_NN
          lysis_NNS buffer_NN (_( 20_CD mM_NN Tris_NNP pH_NN 7_CD ._. 4_CD ,_, 137_CD mM_NN NaCl_NNP ,_, 25_CD mM_NN
          β-glycerolphosphate_JJ pH_NN 7_CD ._. 4_CD ,_, 2_CD mM_NN PPiNa_NNP ,_, 2_CD mM_NN EDTA_NNP pH_NN 7_CD ._. 4_CD ,_,
          1_CD %_NN Triton_NNP X-_NNP 100_CD ,_, and_CC 10_CD %_NN glycerol_NN )_) ._. Following_VBG the_DT
          addition_NN of_IN lysis_NNS buffer_NN ,_, samples_NNS were_VBD incubated_JJ on_IN ice_NN
          for_IN 15_CD min_NN and_CC then_RB centrifuged_JJ at_IN 13_CD ,_, 600_CD ×_NN 
          g_SYM for_IN 5_CD min_NN at_IN 4_CD °_NN C_NNP ._. Cell_NNP lysates_NNS
          were_VBD transferred_VBN to_TO fresh_JJ microcentrifuge_NN tubes_NNS ._. Protein_NNP
          concentrations_NNS of_IN the_DT cell_NN lysates_NNS were_VBD quantified_VBN as_IN
          described_VBN [_NN 65_CD ]_NN and_CC the_DT samples_NNS then_RB stored_VBD at_IN -_: 80_CD °_NN C_NNP
          until_IN analyzed_VBN by_IN western_JJ immunoblot_NN techniques_NNS ._.
        
        
          Exposure_NNP of_IN osteoblasts_NNS to_TO purified_JJ bacterial_JJ
          products_NNS
          Cultured_NNP normal_JJ human_JJ osteoblasts_NNS were_VBD seeded_VBN into_IN
          6_CD -_: well_RB cluster_NN plates_NNS in_IN medium_NN provided_VBN by_IN the_DT
          manufacturer_NN and_CC incubated_JJ at_IN 37_CD °_NN C_NNP in_IN a_DT 5_CD %_NN CO_NNP 
          2_CD atmosphere_NN ._. After_IN the_DT cells_NNS reached_VBN
          approximately_RB 80_CD %_NN confluence_NN (_( 5_CD to_TO 9_CD days_NNS )_) ,_, they_PRP were_VBD
          treated_VBN with_IN purified_JJ lipopolysaccharide_NN (_( LPS_NNP )_) ,_,
          staphylococcal_NN peptidoglycan_NN ,_, teichoic_JJ acid_NN ,_, or_CC
          staphylococcal_NN enterotoxin_NN A_DT (_( Sigma_NNP Chemical_NNP Company_NNP ,_, St_NNP ._.
          Louis_NNP ,_, Mo_NNP ._. )_) over_IN a_DT range_NN of_IN concentrations_NNS ._. Following_VBG a_DT
          24_CD h_NN exposure_NN ,_, osteoblasts_NNS were_VBD lysed_JJ and_CC total_JJ
          osteoblast_NN proteins_NNS isolated_VBN and_CC analyzed_VBN using_VBG western_JJ
          immunoblot_NN techniques_NNS ._.
        
        
          Transwell_NNP co-cultures_JJ of_IN S_NNP ._. aureusand_NN normal_JJ mouse_NN
          osteoblasts_NNS
          Normal_NNP mouse_NN osteoblasts_NNS were_VBD grown_VBN in_IN 12_CD -_: well_RB cluster_NN
          plates_NNS containing_VBG 1_CD ._. 5_CD mL_NN of_IN growth_NN medium_NN per_IN well_RB ._. 
          S_NNP ._. aureus_NN at_IN an_DT MOI_NNP of_IN 25_CD :_: 1_CD ,_, 75_CD :_: 1_CD ,_,
          or_CC 250_CD :_: 1_CD was_VBD added_VBN separately_RB to_TO Transwell_NNP ®_NN cell_NN culture_NN
          chamber_NN inserts_NNS in_IN 0_CD ._. 5_CD ml_NN of_IN growth_NN medium_NN ._. Inserts_NNP were_VBD
          placed_VBN into_IN the_DT 12_CD -_: well_RB plates_NNS containing_VBG osteoblasts_NNS for_IN
          45_CD minutes_NNS ._. The_DT polycarbonate_NN membrane_NN at_IN the_DT base_NN of_IN
          each_DT chamber_NN insert_NN contains_VBZ pores_VBZ 0_CD ._. 45_CD μm_NN in_IN size_NN and_CC
          precludes_VBZ direct_JJ interaction_NN between_IN the_DT bacteria_NNS and_CC
          osteoblasts_NNS ._. However_RB ,_, the_DT pore_NN size_NN allows_VBZ for_IN the_DT
          exchange_NN of_IN extracellular_NN products_NNS ._. Following_VBG the_DT
          45_CD -_: minute_NN incubation_NN ,_, chamber_NN inserts_NNS were_VBD removed_VBN ,_,
          osteoblasts_NNS lysed_JJ and_CC proteins_NNS analyzed_VBD using_VBG western_JJ
          immunoblot_NN techniques_NNS ._.
        
        
          FACS_NNP analysis_NN of_IN apoptosis_NNS
          The_DT Vybrant_NNP Apoptosis_NNP Assay_NNP Kit_NNP (_( Molecular_NNP Probes_NNP ,_,
          Eugene_NNP ,_, OG_NNP )_) was_VBD used_VBN to_TO detect_VB osteoblast_NN apoptosis_NNS ._.
          Briefly_NNP ,_, normal_JJ mouse_NN osteoblasts_NNS were_VBD infected_VBN with_IN 
          S_NNP ._. aureus_NN strain_NN UAMS-_NNP 1_CD at_IN various_JJ
          MOI_NNP in_IN the_DT presence_NN and_CC absence_NN of_IN an_DT anti-_NN TRAIL_NNP
          polyclonal_NN antibody_NN (_( rabbit_NN anti-human_JJ TRAIL_NNP /_NN Apo_NNP 2_CD L_NNP ,_, Cell_NNP
          Sciences_NNPS ,_, Inc_NNP ._. ,_, Norwood_NNP ,_, MA_NNP )_) ._. Following_VBG a_DT 45_CD -_: minute_NN
          incubation_NN ,_, osteoblasts_NNS were_VBD washed_VBN 3_CD times_NNS with_IN HBSS_NNP and_CC
          incubated_JJ in_IN medium_NN containing_VBG 25_CD μg_NN of_IN gentamicin_NN per_IN ml_NN
          to_TO kill_VB extracellular_NN bacteria_NNS ._. Anti-_NNP TRAIL_NNP antibody_NN was_VBD
          added_VBN to_TO the_DT cultures_NNS again_RB to_TO neutralize_NN any_DT TRAIL_NNP
          produced_VBN by_IN the_DT osteoblasts_NNS in_IN response_NN to_TO the_DT infection_NN ._.
          At_IN various_JJ times_NNS post-infection_JJ ,_, osteoblasts_NNS were_VBD
          incubated_JJ with_IN 0_CD ._. 025_CD %_NN trypsin-_NN 0_CD ._. 01_CD %_NN EDTA_NNP for_IN 10_CD min_NN at_IN
          37_CD °_NN C_NNP ,_, collected_VBN by_IN centrifugation_NN ,_, washed_VBN with_IN PBS_NNP ,_, and_CC
          stained_JJ with_IN Alexa_NNP Fluor_NNP 488_CD annexin_NN V_NNP and_CC propidium_NN
          iodide_NN according_VBG to_TO published_VBN guidelines_NNS ._. Cells_NNP were_VBD
          analyzed_VBN using_VBG a_DT fluorescence-activated_JJ cell_NN sorter_NN
          (_( FACSCalibur_NNP ,_, Becton_NNP Dickinson_NNP ,_, San_NNP Jose_NNP ,_, CA_NNP )_) ._.
        
        
          Detection_NNP of_IN Caspase-_NNP 8_CD activity_NN
          Caspase-_NNP 8_CD enzymatic_JJ activity_NN was_VBD detected_VBN using_VBG a_DT
          caspase-_NN 8_CD fluorometric_JJ kit_NN (_( R_NN &_CC D_NNP Systems_NNPS ,_, Minneapolis_NNP ,_,
          MN_NNP )_) according_VBG to_TO published_VBN guidelines_NNS ._. Briefly_NNP ,_, cultured_JJ
          normal_JJ mouse_NN osteoblasts_NNS were_VBD infected_VBN with_IN 
          S_NNP ._. aureus_NN in_IN the_DT presence_NN or_CC
          absence_NN of_IN anti-_NN TRAIL_NNP polyclonal_NN antibody_NN as_IN described_VBN
          above_IN or_CC stimulated_VBN with_IN cychloheximide_NN (_( 10_CD μg_NN /_NN ml_NN )_) ._. At_IN
          various_JJ time_NN points_NNS ,_, osteoblasts_NNS were_VBD lysed_JJ with_IN lysis_NNS
          buffer_NN and_CC total_JJ protein_NN concentration_NN determined_VBN as_IN
          described_VBN [_NN 65_CD ]_NN ._. Cell_NNP lysates_NNS were_VBD incubated_JJ with_IN the_DT
          caspase-_NN 8_CD fluorogenic_JJ substrate_NN (_( IETD-AFC_NNP )_) at_IN 37_CD °_NN C_NNP for_IN 2_CD
          h_NN ._. Sample_NNP fluorescence_NN was_VBD detected_VBN using_VBG a_DT CytoFluor_NNP
          multi-well_JJ plate_NN reader_NN (_( Applied_NNP Biosystems_NNP ,_, Foster_NNP City_NNP ,_,
          CA_NNP )_) ,_, where_WRB the_DT amount_NN of_IN fluorescence_NN directly_RB
          corresponds_NNS to_TO the_DT amount_NN of_IN caspase-_NN 8_CD activity_NN ._.
        
        
          SDS-PAGE_NNP and_CC western_JJ immunoblot_NN analysis_NN
          Equivalent_NNP amounts_NNS of_IN protein_NN from_IN the_DT cell_NN lysate_NN
          fractions_NNS described_VBD above_IN were_VBD mixed_VBN with_IN concentrated_VBN 2_CD X_NNP
          sodium_NN dodecyl_NN sulfate_NN (_( SDS_NNP )_) -_: polyacrylamide_NN gel_NN
          electrophoresis_NNS (_( PAGE_NNP )_) loading_NN buffer_NN (_( 0_CD ._. 125_CD M_NNP Tris-_NNP HCL_NNP
          [_NN pH_NN 6_CD ._. 8_CD ]_NN ,_, 4_CD %_NN [_NN wt_NN /_NN vol_NN ]_NN SDS_NNP ,_, 10_CD %_NN [_NN vol_NN /_NN vol_NN ]_NN
          2_CD -_: mercaptoethanol_NN ,_, 20_CD %_NN [_NN vol_NN /_NN vol_NN ]_NN glycerol_NN ,_, 0_CD ._. 01_CD %_NN [_NN wt_NN /_NN vol_NN ]_NN
          bromophenol_NN blue_JJ )_) ,_, boiled_VBD for_IN 5_CD min_NN ,_, and_CC cleared_VBN by_IN
          centrifugation_NN at_IN 13_CD ,_, 600_CD ×_NN 
          g_SYM for_IN 5_CD min_NN ._. Osteoblast_NNP proteins_NNS
          were_VBD separated_VBN by_IN SDS-PAGE_NNP as_IN described_VBN by_IN Laemmli_NNP [_NN 66_CD ]_NN
          ._. The_DT proteins_NNS were_VBD then_RB electrophoretically_RB transferred_VBN
          to_TO polyvinylidene_NN difluoride_NN membranes_NNS (_( Fisher_NNP Biotech_NNP )_) ,_,
          using_VBG the_DT Mini_NNP Trans-_NNP Blot_NNP apparatus_NN (_( BioRad_NNP ,_, Hercules_NNP ,_,
          CA_NNP )_) at_IN 300_CD mA_NN for_IN 1_CD h_NN at_IN 4_CD °_NN C_NNP according_VBG to_TO manufacturer_NN 's_POS
          recommendations_NNS ._. Membranes_NNP were_VBD blocked_VBN with_IN Buffer_NNP A_DT
          (_( Tris-buffered_NNP saline_NN (_( TBS_NNP )_) (_( Bio-_NNP Rad_NNP )_) containing_VBG 5_CD ._. 0_CD %_NN
          skim_VB milk_NN and_CC 0_CD ._. 5_CD %_NN Tween_NNP 20_CD (_( Sigma_NNP )_) )_) for_IN 1_CD h_NN with_IN gentle_JJ
          shaking_VBG ,_, then_RB washed_VBN with_IN Buffer_NNP B_NNP (_( TBS_NNP containing_VBG 0_CD ._. 1_CD %_NN
          Tween_NNP 20_CD )_) 3_CD times_NNS for_IN 5_CD min_NN each_DT ._. A_DT two-step_JJ detection_NN
          method_NN was_VBD used_VBN to_TO identify_VB TRAIL_NNP ._. Blots_NNP were_VBD first_JJ
          incubated_JJ overnight_JJ with_IN gentle_JJ shaking_VBG at_IN 4_CD °_NN C_NNP with_IN
          rabbit_NN anti-human_JJ TRAIL_NNP polyclonal_NN antibodies_NNS (_( Cell_NNP
          Sciences_NNPS ,_, Inc_NNP ._. ,_, Norwood_NNP ,_, MA_NNP )_) at_IN a_DT concentration_NN of_IN 0_CD ._. 2_CD
          μg_NN /_NN ml_NN in_IN Buffer_NNP A_DT ._. Membranes_NNP were_VBD then_RB washed_VBN the_DT
          following_VBG day_NN 3_CD times_NNS for_IN 5_CD min_NN in_IN Buffer_NNP B_NNP with_IN gentle_JJ
          shaking_VBG ,_, then_RB incubated_JJ for_IN 1_CD h_NN with_IN gentle_JJ shaking_VBG at_IN
          room_NN temperature_NN with_IN horseradish_NN peroxidase_NN
          (_( HRP_NNP )_) -_: conjugated_JJ anti-rabbit_JJ immunoglobulin_NN G_NNP (_( Amersham_NNP
          Biosciences_NNP Corp_NNP ._. ,_, Piscataway_NNP ,_, NJ_NNP )_) diluted_VBN 1_CD :_: 5000_CD in_IN
          Buffer_NNP A_DT ._. Reactive_NNP proteins_NNS were_VBD visualized_JJ by_IN enhanced_JJ
          chemiluminescence_NN (_( Amersham_NNP ,_, Arlington_NNP Heights_NNP ,_, IL_NNP )_)
          following_VBG exposure_NN to_TO X-_NNP ray_NN film_NN and_CC subsequent_JJ film_NN
          development_NN ._.
        
      
      
        Authors_NNP Contributions_NNP
        EHA_NNP carried_VBD out_RP the_DT studies_NNS to_TO examine_VB the_DT influence_NN of_IN
        purified_JJ bacterial_JJ products_NNS and_CC cell_NN culture_NN inserts_NNS ,_, and_CC
        measures_NNS of_IN apoptosis_NNS
        FAR_RB performed_VBD the_DT caspase_NN studies_NNS
        IM_NNP performed_VBD FACS_NNP analysis_NN
        JA_NNP performed_VBD FACS_NNP analysis_NN
        KLB_NNP conceived_VBD of_IN the_DT design_NN of_IN the_DT study_NN
        MCH_NNP conceived_VBD of_IN the_DT design_NN of_IN the_DT study_NN ,_, and_CC
        coordinated_VBN the_DT experiments_NNS
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN
      
    
  
